Guia prático de urticária para grupos especiais de pacientes
Practical guide to urticaria for special patient groups
Larissa Silva Brandão; Janaina Michelle Lima Melo; Gabriela Andrade Dias; Eli Mansour; Rozana de Fátima Gonçalves; Carolina Tavares De-Alcântara; Fernanda Lugao Campinhos; Daniela Farah Teixeira Raeder; Leila Vieira Borges Trancoso-Neves; Régis de Albuquerque Campos; Solange Oliveira Rodrigues Valle; Rosana Câmara Agondi; Alfeu Tavares Franca; Luis Felipe Chiaverini Ensina
Resumo
A urticária crônica é uma condição que afeta mais de um milhão de brasileiros, com grande impacto na qualidade de vida. Mesmo com diretrizes bem difundidas para o seu diagnóstico e tratamento, seu manejo pode ser desafiador em pacientes pediátricos, idosos e gestantes. Para auxiliar o médico especialista nestes casos, o Departamento Científico de Urticária da Associação Brasileira de Alergia e Imunologia elaborou esta revisão com as principais dúvidas e dificuldades referentes ao tema nestes grupos de pacientes.
Palavras-chave
Abstract
Chronic urticaria is a condition that affects more than a million Brazilians with a significant impact on quality of life. Although there are well-established guidelines for diagnosis and treatment, the management of chronic urticaria may be challenging in pediatric, older, and pregnant patients. With the purpose of helping specialists manage these cases, the Urticaria Scientific Department of the Brazilian Association of Allergy and Immunology prepared this review with the most common doubts and difficulties about this topic in those patient groups.
Keywords
Referências
1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The International EAACI/GA2LEN/EuroGuiDerm/ APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. Allergy. 2022;77(3):734-66.
2. Ensina LF, Valle SOR, Campos RA, Agondi R, Criado P, Bedrikow RB, et al. Guia prático da Associação Brasileira de Alergia e Imunologia para o diagnóstico e tratamento das urticárias baseado em diretrizes internacionais. Arq Asma Alerg Imunol. 2019;3(4):382-92.
3. Ben-Shoshan M, Grattan CE. Management of Pediatric Urticaria with Review of the Literature on Chronic Spontaneous Urticaria in Children. J Allergy Clin Immunol Pract. 2018;6(4):1152-61.
4. Cetinkaya PG, Soyer O, Esenboga S, Sahiner UM, Teksam O, Sekerel BE. Predictive factors for progression to chronicity or recurrence after the first attack of acute urticaria in preschool-age children. Allergol Immunopathol (Madr). 2019;47(5):484-90.
5. Guo C, Saltoun C. Urticaria and angioedema. Allergy Asthma Proc. 2019;40(6):437-40.
6. Minasi D, Manti S, Chiera F, Licari A, Marseglia GL. Acute urticaria in the infant. Pediatr Allergy Immunol. 2020;31(S26):49-51.
7. Sabroe RA. Acute Urticaria. Immunol Allergy Clin North Am. 2014;34(1):11-21.
8. Caffarelli C, Paravati F, El Hachem M, Duse M, Bergamini M, Simeone G, et al. Management of chronic urticaria in children: A clinical guideline. Ital J Pediatr. 2019;45(1):1-25.
9. Fricke J, Ávila G, Keller T, Weller K, Lau S, Maurer M, et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy Eur J Allergy Clin Immunol. 2020;75(2):423-32.
10. Netchiporouk E, Sasseville D, Moreau L, Habel Y, Rahme E, BenShoshan M. Evaluating comorbidities, natural history, and predictors of early resolution in a cohort of children with Chronic Urticaria. JAMA Dermatology. 2017;153(12):1236-42.
11. Saini S, Shams M, Bernstein JA, Maurer M. Urticaria and Angioedema Across the Ages. J Allergy Clin Immunol Pract. 2020;8(6):1866-74.
12. Brandão L, Araujo C, Moura AC, Bruscky D, Dela Bianca AC, Camelo-Nunes I, et al. Chronic urticaria in children: a real-life study. J Allergy Clin Immunol. 2021;147(2):AB25.
13. Lachover-Roth I, Rabie A, Cohen-Engler A, Rosman Y, Meir-Shafrir K, Confino-Cohen R. Chronic urticaria in children – New insights from a large cohort. Pediatr Allergy Immunol. 2021;32(5):999-1005.
14. Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M. Autoimmune chronic spontaneous urticaria: What we know and what we do not know. J Allergy Clin Immunol. 2017;139(6):1772-81.
15. Schmetzer O, Lakin E, Topal FA, Preusse P, Freier D, Church MK, et al. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J Allergy Clin Immunol. 2018;142(3):876-82.
16. Barzilai O, Ram M, Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol. 2007;19(6):636‑43.
17. Sahiner UM, Civelek E, Tuncer A, Yavuz ST, Karabulut E, Sackesen C, et al. Chronic urticaria: Etiology and natural course in children. Int Arch Allergy Immunol. 2011;156(2):224-30.
18. Caffarelli C, Cuomo B, Cardinale F, Barberi S, Dascola C, Agostinis F, et al. Aetiological Factors Associated with Chronic Urticaria in Children: A Systematic Review. Acta Derm Venereol. 2013;93(3):268‑72.
19. Azkur D, Civelek E, Toyran M, Mısırlıoglu ED, Erkoçoglu M, Kaya A, et al. Clinical and etiologic evaluation of the children with chronic urticaria. Allergy Asthma Proc. 2016;37(6):450-7.
20. Ensina LF, Bastos PGA, de Lacerda AE, de Araujo CA, CameloNunes I, Solé D. Comments on Balp et al. Pediatr Allergy Immunol. 2018;29(6):669-70.
21. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, BallmerWeber B, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy Eur J Allergy Clin Immunol. 2018;73(7):1393-414.
22. Miles LM, Gabrielli S, Le M, Netchiporouk E, Baum S, Greenberger S, et al. Clinical Characteristics, Management, and Natural History of Chronic Inducible Urticaria in a Pediatric Cohort. Int Arch Allergy Immunol. 2021;182(8):757-64.
23. Bal F, Kahveci M, Soyer O, Sekerel BE, Sahiner UM. Chronic inducible urticaria subtypes in children: Clinical features and prognosis. Genuneit J, editor. Pediatr Allergy Immunol. 2021;32(1):146-52.
24. Giavina-Bianchi P, Aun MV, Motta AA, Kalil J, Castells M. Classification of angioedema by endotypes. Clin Exp Allergy. 2015;45(6):1142-3.
25. Pattanaik D, Lieberman JA. Pediatric Angioedema. Curr Allergy Asthma Rep. 2017;17(9):60.
26. Hawro T, Ohanyan T, Schoepke N, Metz M, Peveling-Oberhag A, Staubach P, et al. The Urticaria Activity Score - Validity, Reliability, and Responsiveness. J Allergy Clin Immunol Pract. 2018;6(4):1185‑90.
27. Weller K, Groffik A, Church MK, Hawro T, Krause K, Metz M, et al. Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014 May;133(5):1365-72, 1372.e1-6.
28. Valle SOR, Dortas-Junior SD, Dias GAC, Motta AA, do-Amaral CSF, Martins EAPR, et al. Ferramentas para avaliação e acompanhamento da urticária crônica. Arq Asma, Alerg e Imunol. 2018;2(2):209‑24.
29. Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, et al. Development, validation, and initial results of the Angioedema Activity Score. Allergy. 2013;68(9):1185-92.
30. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CUQ2oL). Allergy. 2005;60(8):1073-8.
31. Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy. 2012;67(10):1289-98.
32. Prati C, Comparin C, Catucci Boza J, Ferreira Cestari T. Validação para o português falado no Brasil do instrumento Escore da Qualidade de Vida na Dermatologia Infantil (CDLQI). Med Cutan Ibero Lat Am. 2010;38(6):229-33.
33. Bruscky DMV, Melo ACCDB, Sarinho ESC. Cross-cultural adaptation and validation of the itching severity scale in children and adolescents with atopic dermatitis. Rev Paul Pediatr. 2017;35(3):244-51.
34. Davis MDP, van der Hilst JCH. Mimickers of Urticaria: Urticarial Vasculitis and Autoinflammatory Diseases. J Allergy Clin Immunol Pract. 2018;6(4):1162-70.
35. Zuberbier T, Maurer M. Urticarial Vasculitis and Schnitzler Syndrome. Immunol Allergy Clin North Am. 2014;34(1):141-7.
36. Hernández-Ostiz S, Prieto-Torres L, Xirotagaros G, Noguera-Morel L, Hernández-Martín, Torrelo A. Autoinflammatory Diseases in Pediatric Dermatology-Part 1: Urticaria-like Syndromes, Pustular Syndromes, and Mucocutaneous Ulceration Syndromes. Actas Dermosifiliogr. 2017;108(7):609-19.
37. Japiassu LG, Bastos PGA, Araújo CA, Camelo-Nunes I, Solé D, Ensina LF. Omalizumabe no tratamento da urticária crônica espontânea em pacientes pediátricos: série de casos. Arq Asma Alerg Imunol. 2018;2(1):78.
38. Cortellazzo Wiel L, Conversano E, Giangreco M, Fagotto L, Genovese MRL, Badina L, et al. Natural history and predictors of recovery in children with chronic spontaneous urticaria. Pediatr Allergy Immunol. 2021;32(1):201-4.
39. Wertenteil S, Strunk A, Garg A. Prevalence estimates for chronic urticaria in the United States: A sex- and age-adjusted population analysis. J Am Acad Dermatol. 2019;81(1):152-6.
40. Kim BR, Yang S, Choi JW, Choi CW, Youn SW. Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study. J Dermatol. 2018;45(1):10-6.
41. Chuamanochan M, Kulthanan K, Tuchinda P, Chularojanamontri L, Nuchkull P. Clinical features of chronic urticaria in aging population. Asian Pacific J Allergy Immunol. 2016;34(3):201-5.
42. Magen E, Mishal J, Schlesinger M. Clinical and laboratory features of chronic idiopathic urticaria in the elderly. Int J Dermatol. 2013;52(11):1387–91.
43. Ban G-Y, Kim M-Y, Yoo H-S, Nahm D-H, Ye Y-M, Shin Y-S, et al. Clinical features of elderly chronic urticaria. Korean J Intern Med. 2014;29(6):800.
44. Curto-Barredo L, Pujol RM, Roura-Vives G, Gimenez-Arnau AM. Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response. Eur J Dermatology. 2019;29(6):627-35.
45. Longhurst HJ, Gonçalo M, Godse K, Ensina LF. Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age. J Allergy Clin Immunol Pract. 2021;9(6):2186-94.
46. Valle SOR, Motta AA, Amaral CS, Ensina LFC, Mallozi MC, Spengler MG, et al. What is new in chronic spontaneous urticaria? Brazilian J Allergy Immunol. 2016;4(1):9-25.
47. França AT, Valle SOR. Urticária e angioedema: diagnóstico e tratamento. 3ª ed. Rio de Janeiro: Revinter; 2014.
48. Brodell LA, Beck LA. Differential diagnosis of chronic urticaria. Ann Allergy, Asthma Immunol. 2008;100(3):181-8.
49. Gellrich FF, Günther C. Schnitzler syndrome. Hautarzt. 2019 Jun 5. English. doi: 10.1007/s00105-019-4434-4.
50. Zuberbier HCT, Maurer M. Urticarial Vasculitis and Schnitzler Syndrome. Immunol Allergy Clin North Am. 2014;34(1):141-7.
51. Magerl M, Altrichter S, Borzova E, Giménez-Arnau A, Grattan CEH, Lawlor F, et al. The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA 2 LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy. 2016;71(6):780-802.
52. Larenas-Linnemann D, Saini SS, Azamar-Jácome AA, JensenJarolim E, Maurer M. Very rarely chronic urticaria can be caused by cancer and if so, resolves with its cure. Allergy Eur J Allergy Clin Immunol. 2018;73(9):1925-6.
53. Faisant C, Armengol G, Bouillet L, Boccon-Gibod I, Villier C, Lévesque H, et al. Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database. J Clin Immunol. 2016;36(1):95-102.
54. Giavina-Bianchi P, Arruda LK, Aun MV, Campos RA, Chong-Neto HJ, Constantino-Silva RN, et al. Diretrizes brasileiras para o diagnóstico e tratamento do angioedema hereditário - 2017. Arq Asma, Alerg Imunol. 2017;1(1):23-48.
55. Ventura MT, Cassano N, Romita P, Vestita M, Foti C, Vena GA. Management of Chronic Spontaneous Urticaria in the Elderly. Drugs Aging. 2015;32(4):271-82.
56. Cataldi M, Maurer M, Taglialatela M, Church MK. Cardiac safety of second‐generation H1‐antihistamines when updosed in chronic spontaneous urticaria. Clin Exp Allergy. 2019;49(12):1615-23.
57. Nettis E, Cegolon L, Di Leo E, Canonica WG, Detoraki A, Baiardini I, et al. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience. Ann Allergy, Asthma Immunol. 2018;120(3):318-23.
58. Martina E, Damiani G, Grieco T, Foti C, Pigatto PDM, Offidani A. It is never too late to treat chronic spontaneous urticaria with omalizumab: Real-life data from a multicenter observational study focusing on elderly patients. Dermatol Ther. 2021;34(2):e14841.
59. Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A. Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up. J Am Acad Dermatol. 2018;79(4):599-614.
60. Lawlor F. Urticaria and Angioedema in Pregnancy and Lactation. Immunol Allergy Clin North Am. 2014;34(1):149-56.
61. Kocatürk E, Al-Ahmad M, Krause K, Gimenez-Arnau AM, Thomsen SF, Conlon N, et al. Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study. Allergy. 2021;76(10):3133-44.
62. Hale TW. Medications and mother’s milk. 15ª ed. Center IR, ed. Pharmasoft Publishing; 2012. p. 352-2519.
63. Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation. J Am Acad Dermatol. 2014;70(3):401. e1-401.e14.
64. Giugliani ERJ, Vieira GO, Elias CLLF, Closs CTK, Issler RM da S, Alves RMNR, et al. Uso de medicamentos e outras substâncias pela mulher durante a amamentação. Soc Bras Pediatr Dep Cient Aleitamento Matern. 2017;4:1-18.
65. Sánchez-Borges M, Ansotegui IJ, Baiardini I, Bernstein J, Canonica GW, Ebisawa M, et al. The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations. World Allergy Organ J. 2021;14(6):100546.
66. Losappio LM, Mirone C, Schroeder JW, Scibilia J, Balossi L, Pastorello EA. Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report. Case Rep Dermatol. 2020;12(3):174-7.
67. Ensina L, Cusato-Ensina A, Camelo-Nunes I, Solé D. Omalizumab as Third-Line Therapy for Urticaria During Pregnancy. J Investig Allergol Clin Immunol. 2017;27(5):326-7.
68. Cuervo-Pardo L, Barcena-Blanch M, Radojicic C. Omalizumab use during pregnancy for CIU: a tertiary care experience. Eur Ann Allergy Clin Immunol. 2016;48(4):145-6.
69. Melo JML, Borges LV, França AT, Dias GA, Ensina LFC, Agondi RC, et al. Guia prático do tratamento com omalizumabe para urticária crônica espontânea. Arq Asma Alerg Imunol. 2020;4(3):289-99.
70. Bauer A, Dickel H, Jakob T, Kleinheinz A, Lippert U, Metz M, et al. Expert consensus on practical aspects in the treatment of chronic urticaria. Allergo J Int. 2021;30(2):64-75.
71. Lehrhoff S, Pomeranz MK. Specific dermatoses of pregnancy and their treatment. Dermatol Ther. 2013;26(4):274-84.
72. Peroni A, Colato C, Schena D, Girolomoni G. Urticarial lesions: If not urticaria, what else? The differential diagnosis of urticaria. J Am Acad Dermatol. 2010;62(4):541-55.
Submetido em:
24/02/2022
Aceito em:
06/03/2022
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email